Asterios Karagiannis Selected Research

Nebivolol

1/2019	Effect of Nebivolol and Olmesartan on 24-Hour Brachial and Aortic Blood Pressure in the Acute Stage of Ischemic Stroke.
2/2014	Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asterios Karagiannis Research Topics

Disease

27	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 03/2007
24	Hypertension (High Blood Pressure) 03/2022 - 08/2005
24	Non-alcoholic Fatty Liver Disease 01/2021 - 05/2006
21	Heart Failure 12/2022 - 04/2007
21	Type 2 Diabetes Mellitus (MODY) 10/2022 - 05/2007
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 01/2007
17	Coronary Disease (Coronary Heart Disease) 01/2019 - 01/2007
14	Obesity 03/2022 - 08/2005
14	Stroke (Strokes) 01/2022 - 07/2007
13	Diabetes Mellitus 01/2022 - 06/2008
11	Atherosclerosis 04/2023 - 04/2007
10	Dyslipidemias (Dyslipidemia) 07/2021 - 06/2008
9	Chronic Renal Insufficiency 01/2022 - 07/2009
8	Inflammation (Inflammations) 03/2022 - 09/2008
7	Alcoholic Fatty Liver 01/2021 - 08/2012
6	Coronary Artery Disease (Coronary Atherosclerosis) 02/2015 - 05/2007
5	Insulin Resistance 03/2022 - 11/2010
5	Ischemic Stroke 01/2019 - 01/2004
4	Myocardial Infarction 01/2022 - 11/2007
4	Body Weight (Weight, Body) 12/2019 - 05/2006
4	Hyperaldosteronism (Conn Syndrome) 01/2018 - 01/2007
4	Vascular Diseases (Vascular Disease) 01/2016 - 01/2009
4	Acute Coronary Syndrome 02/2015 - 01/2009
4	Obstructive Sleep Apnea 09/2014 - 01/2014
4	Abdominal Obesity 12/2010 - 02/2007
3	Systemic Scleroderma (Systemic Sclerosis) 04/2023 - 12/2020
3	COVID-19 01/2022 - 11/2021
3	Infections 11/2021 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2017
3	Weight Loss (Weight Reduction) 12/2020 - 05/2007
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2016 - 07/2014
3	Crohn Disease (Crohn's Disease) 01/2016 - 07/2014
3	Ulcerative Colitis 01/2016 - 07/2014
3	Atherosclerotic Plaque (Atheroma) 01/2015 - 03/2007
3	Essential Hypertension 02/2014 - 09/2006
3	Unstable Angina 09/2013 - 11/2007
3	Necrosis 01/2013 - 01/2010
2	Anemia 01/2022 - 02/2009
2	Diabetes Complications 11/2021 - 01/2014
2	Hypercholesterolemia 07/2021 - 02/2008
2	Fibrosis (Cirrhosis) 01/2019 - 01/2018
2	Liver Diseases (Liver Disease) 01/2019 - 02/2014
2	Proteinuria 01/2019 - 01/2015
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 10/2018 - 03/2008
2	Homozygous Familial Hypercholesterolemia 01/2018 - 01/2014
2	Hyperkalemia 01/2018 - 05/2005
2	Weight Gain 01/2018 - 03/2008
2	Fatty Liver 01/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

53	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2021 - 01/2007
23	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 08/2005
21	Atorvastatin (Lipitor)FDA Link 07/2021 - 05/2006
18	LipidsIBA 07/2021 - 03/2007
12	LDL CholesterolIBA 03/2018 - 05/2006
12	Uric Acid (Urate)IBA 12/2017 - 05/2005
10	SodiumIBA 12/2022 - 01/2016
10	oxidized low density lipoproteinIBA 03/2018 - 03/2007
10	Triglycerides (Triacylglycerol)IBA 03/2018 - 05/2006
9	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 05/2006
7	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2022 - 01/2016
7	AdipokinesIBA 03/2022 - 01/2010
7	CholesterolIBA 01/2019 - 05/2006
7	HDL CholesterolIBA 03/2018 - 01/2007
6	Rosuvastatin Calcium (Crestor)FDA Link 07/2021 - 07/2009
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 02/2007
5	Ezetimibe (Zetia)FDA Link 07/2021 - 02/2008
5	C-Reactive ProteinIBA 01/2019 - 05/2006
5	Fibric Acids (Fibrates)IBA 03/2018 - 01/2009
4	AldosteroneIBA 10/2018 - 09/2008
4	AdiponectinIBA 10/2018 - 05/2007
4	Pioglitazone (Actos)FDA Link 01/2018 - 03/2008
4	EnzymesIBA 01/2018 - 12/2010
4	Spironolactone (Aldactone)FDA LinkGeneric 01/2018 - 01/2007
4	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2014
4	Vitamin D FDA LinkGeneric 05/2014 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 04/2023 - 05/2006
3	dapagliflozinIBA 08/2022 - 01/2021
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 12/2019
3	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2018
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 03/2008
3	Atenolol (Tenormin)FDA LinkGeneric 02/2014 - 09/2006
3	aliskiren FDA Link 02/2014 - 04/2007
3	CytokinesIBA 01/2014 - 01/2014
3	Orlistat (Xenical)FDA Link 11/2011 - 05/2006
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2010 - 04/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2023 - 10/2006
2	empagliflozinIBA 08/2022 - 11/2017
2	Drug CombinationsIBA 07/2021 - 01/2011
2	SymportersIBA 01/2021 - 01/2016
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2020 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019 - 08/2009
2	Nebivolol FDA Link 01/2019 - 02/2014
2	Vitamin E FDA LinkGeneric 01/2018 - 01/2018
2	mipomersenIBA 01/2018 - 01/2014
2	BMS201038IBA 01/2018 - 01/2014

Therapy/Procedure

15	Therapeutics 01/2021 - 05/2005
7	Secondary Prevention 12/2018 - 10/2007
5	Drug Therapy (Chemotherapy) 12/2020 - 10/2011
4	Renal Dialysis (Hemodialysis) 12/2020 - 01/2008
4	Percutaneous Coronary Intervention 01/2016 - 04/2010
3	Glycemic Control 12/2019 - 05/2007